‼️ EMA has started evaluating an application for the authorisation of an adapted version of Spikevax targeting the original virus that causes #COVID19 and its #Omicron subvariants BA.4/5

#AdaptedVaccines #COVID19vaccines

🐦🔗: https://nitter.eu/EMA_News/status/1574723403025592321